Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody drugs
Biotech
Roche inks $1.53B deal for Simcere’s B-cell-targeting antibody
Simcere is eligible to receive up to $1.53 billion in total payments, plus royalties on future sales.
Marissa Russo
Sep 1, 2026 10:41am
Chai tees up BMS AI antibody discovery collab
Aug 20, 2026 10:55am
Chai brews up $400M series C to fuel AI used by Lilly and Pfizer
Jul 14, 2026 10:03am
Fierce Pharma
GSK's Tesaro, AnaptysBio lock horns over Jemperli agreement
Nov 21, 2025 9:46am
Leads Biolabs hits Hong Kong stock exchange in $189M IPO
Jul 25, 2025 10:59am
Sino Biopharm buys Merck’s PD-1xVEGF bispecific partner LaNova
Jul 15, 2025 10:16am
